Drugs for Neglected Diseases initiative

News

Non-profit DNDi has licensed a dengue therapy from India's SII, paving the way for a phase 3 trial in Malaysia, Thailand, and Brazil.

News

Amgen's Imdelltra and AstraZeneca's Imfinzi have improved survival compared to Imfinzi alone as first-line maintenance treatment for ES-SCLC.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.